A Century of Missteps, Manipulations, and Misdeeds. Medicine must be reclaimed as a public good, not a marketplace of manipulation.
The past century has seen astonishing medical advances, from antibiotics to organ transplants and precision diagnostics. Yet behind the celebrated breakthroughs lies a shadowed record of harm, deceit, and systemic failure.
The history of modern medicine is not only a story of progress but also one of unethical experimentation, corporate manipulation, regulatory capture, and public betrayal. I have witnessed this firsthand in my own career: when I proposed nutritional medicine approaches to prevention and early treatment, I was attacked by medical boards, chastised by medical colleges and silenced by bureaucracies beholden to pharmaceutical interests.
My work on vitamin C, cancer, and AIDS brought harassment from authorities, culminating in legal battles I was forced to fight—and win in the Supreme Court —at great personal cost. During the COVID-19 pandemic, my pleas to government leaders to adopt simple, life-saving measures like vitamin D, C and zinc were ignored, while experimental genetic injections were pushed on the public without transparency or informed consent.
Over decades I have seen colleagues censured, evidence suppressed, and patients left to suffer—all because profit and political control took precedence over genuine health and healing. Its still happening and patients are dying unnecessarily from the turbo cancers caused by the mRNA vaccines.
The pattern begins with unethical human experimentation and consent failures. In certain landmark cases over the past decades we find medical science mis-stepping into exploitation — from the decades-long denial of treatment in the Tuskegee Syphilis Study, to more recent oversight-failures in clinical trials in low-income countries when pharmaceutical firms prioritised expedience over ethics.
I have observed similar dynamics in my own work: when simple nutritional protocols were sidelined, when investigative treatment options were blocked on the grounds of “non-standard care”, even though patient welfare was at stake, and when regulatory and board actions were taken not for patient safety but to suppress dissenting therapeutic voices.
Next comes the distortion of data, selective reporting and publication bias. The re-analysis of Study 329 revealed that the antidepressant paroxetine was neither safe nor effective in adolescents, despite original favourable publications.